{"id":"W2508701852","doi":"10.1182/blood.v124.21.3084.3084","title":"A Phase 1 -2 Study of Brentuximab Vedotin (Bv) and Bendamustine (B) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Bendamustine; Medicine; Internal medicine; Oncology; Regimen; Refractory (planetary science); Salvage therapy; Progressive disease; Chemotherapy; Lymphoma; Surgery; Gastroenterology; Rituximab; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001950921,0.001421009,0.001747638,0.0004852086,0.0005148972,0.0009501413,0.0007844951,0.001348722,0.003018097],"category_scores_gemma":[0.0008734888,0.0006659482,0.00124756,0.000321118,0.001040251,0.001027043,0.0003470111,0.003522141,0.0007747443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008624993,"about_ca_system_score_gemma":0.001274972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009523034,"about_ca_topic_score_gemma":0.002003586,"domain_scores_codex":[0.9992933,0.0003784447,0.00002610444,0.00009643011,0.00004824144,0.0001574257],"domain_scores_gemma":[0.9993211,0.0001020659,0.00006703124,0.0000418191,0.00003757936,0.0004304127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6100962,0.2502927,0.007878735,0.0006171055,0.0008981396,0.0004688327,0.0005113562,0.003241287,0.05377822,0.0005402289,0.003033236,0.06864405],"study_design_scores_gemma":[0.3415163,0.645493,0.006999046,0.00001821763,0.0001648708,0.0001458284,0.00005425646,0.0007864002,0.002561494,0.0001974432,0.002041102,0.00002205912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923198,0.001131339,0.0004742795,0.0004294331,0.0001376429,0.00336479,0.0006709413,0.00004610834,0.001425708],"genre_scores_gemma":[0.9884525,0.001090322,0.001636836,0.0009462911,0.0002043325,0.003344173,0.001591736,0.00002354774,0.002710294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003018097,"threshold_uncertainty_score":0.01031756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007415717431819893,"score_gpt":0.2337966334996848,"score_spread":0.2263809160678649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}